YOUR GO-TO INTELLIGENCE RESOURCE FOR THE SCHOLARLY PUBLISHING INDUSTRY

IBM Watson Health and EBSCO Information Services (EBSCO) have announced a strategic collaboration aimed towards enhancing clinical decision support (CDS) and operations for healthcare providers and health systems. The companies are combining their respective solution suites – DynaMed® and IBM® Micromedex® with Watson™ – into a single, high-value global solution called ‘DynaMed and Micromedex with Watson.’ The combined solution suite will be designed to bring together drug and disease content, into a single source for evidence-based insights to help inform clinical decisions.

DynaMed provides peer-reviewed clinical content, including systematic literature reviews in 28 specialties for comprehensive disease topics, health conditions, and abnormal findings to highly focused topics on evaluation, differential diagnosis, and management. The content undergoes a rigorous, seven-step process, giving clinicians access to current, evidence-based diagnostic and therapeutic recommendations. IBM Micromedex is an online reference database for medication information. It is used by more than 4,500 hospitals and health systems worldwide to support decision-making in medication therapy management, disease and condition management, toxicology, alternative medicine and patient education.

IBM Micromedex with Watson is designed to use artificial intelligence (AI) and natural language processing (NLP) to bypass keyword searches in favour of a more conversational approach to searching drug content. DynaMed and Micromedex with Watson is expected to be available for general adoption in April, 2020. IBM Watson Health and EBSCO Information Services will also continue to sell the IBM Micromedex with Watson and DynaMed solution suites separately in order to offer flexible options to help meet customers’ needs.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.